Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2002, p. 1069-1070, Vol. 40, No. 3
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.3.1069-1070.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Clinical Virology,1 Department of Haematology,2 Department of Child Health ,3 Department of Neurology, Christian Medical College and Hospital, Vellore-632004, India4
Received 2 July 2001/ Returned for modification 17 November 2001/ Accepted 21 December 2001
|
|
|---|
|
|
|---|
(This research forms part of the Ph.D. thesis work of D. J. Manayani.)
Twenty-eight EV isolates tested were obtained from cerebrospinal fluid, brain biopsy, throat, and rectal swab specimens in primary monkey kidney (PMK) or rhabdomyosarcoma (RD) cell cultures between September 1998 and August 2000 from patients attending the Christian Medical College and Hospital, Vellore, India. Stock strains of poliovirus serotypes 1, 2, and 3 and coxsackievirus B (CB) serotypes 3, CB5 (Centers for Disease Control and Prevention, Atlanta, Ga.), and CB4 (courtesy Gagandeep Kang, Wellcome Research Laboratory, Vellore, India) were also tested. The LBM pools (A to H) (Staten Serum Institut, Copenhagen, Denmark) were used as recommended by the supplier.
The 304-bp nested PCR product generated using universal EV primers from the 5' noncoding region (5' NCR) (1, 2, 7) of EV isolates was subjected to restriction enzyme (RE) analysis with three enzymes, BglI, StyI, and Asp700 (XmnI) (Boehringer Mannheim Roche, Mannheim, Germany) (4).
For sequencing, the RNA was extracted from the infected-cell culture supernatant of the RD cell line by using the QIAamp viral RNA kit (Qiagen Gmbh, Hilden, Germany). The primer pairs 012 and 011 or 040 and 011 generated amplicons of approximately 450 bp that span the VP1-2A region of the EV genome (10). Following cycle sequencing with fluorescent dideoxy-chain terminators, the products were sequenced with an automated genetic analyzer (ABI 310 analyzer; PE Applied Biosystems, Foster City, Calif.). Sequences (GenBank) that match the VP1 sequence of the isolates were identified using BLAST. The percent identity score of the VP1 sequence of EV isolates with the GenBank EV sequences that showed maximum identity, as well as the next closest identity, was calculated using ClustalW (12). If the pairwise identity scores of VP1 sequences of the test strain were 75% or more with respect to any particular EV GenBank sequence, then it was identified as the homologous serotype (11).
The results of typing of the 28 EV isolates are shown in Table 1. Of 27 isolates tested, 26 (96%) were serotyped by the LBM pool-based neutralization. Primers from the VP1-2A region amplified all 28 EV isolates, and 27 (96%) of them could be assigned a serotype by sequencing. The pairwise identity score for EV isolates from this study with the respective homologous GenBank sequences ranged from 78 to 89%; with the exception of one isolate, the pairwise identity scores to the closest heterologous sequences were in the range of 50 to 68%. Excluding the one untypeable isolate, identical results were obtained both by LBM pool typing and by partial sequencing of VP1 for 22 (85%) of 26 tested isolates.
|
View this table: [in a new window] |
TABLE 1. Typing of EV isolates by molecular and serological methods
|
This study showed that there was a high degree of agreement between conventional serotyping and typing by sequencing. We were able to assign a serotype for 26 of 27 clinical isolates by sequencing, and in 22 of them the serotype assignment was identical to that obtained by conventional typing. Discordant typing results were obtained for four isolates. This discordance between serotyping by LBM pool and sequencing could occur due to antigenic variations or viral aggregation (11). Typing of isolates with discordant results by using monospecific sera has shown sequencing to be the accurate method of typing (11). In the study reported here, typing with monospecific sera was not carried out. The isolate that could not be typed by sequencing was also not typeable by conventional methods and may represent a unique type. Serial subcultures to achieve a sufficient concentration of virus for conventional typing delayed the typing results. On the other hand, typing data were available following PCR and sequencing within a few days. Thus, PCR and subsequent sequencing offers the dual advantage of rapidity and the ability to detect previously undescribed serotypes.
This study showed greater agreement between PCR sequencing and conventional typing than did that of Oberste et al. (11). Also, we were able to obtain sequencing data with the use of primers 011 and 012, compared to the five primer pairs used by Oberste et al. (11). These differences are most probably because fewer serotypes were represented in our set of clinical samples than were present in the other study (11). Since regional laboratories may have to deal with fewer serotypes of EV, it is possible that they could obtain typing data for most isolates by using fewer primer pairs for sequencing.
In contrast to the results with PCR and sequencing, the results of typing by PCR-RFLP were disappointing. We used a different primer pair in the nested round for PCR-RFLP than was used by Kuan (4). However, our primer pairs spanned the same 5' NCR, generating a slightly larger PCR product (304 versus 297 bp) (4). Also, half of the prototype strains did not match the specific patterns described by Kuan (4). Variations may occur in the 5' NCR of EVs (13), and this possibly will occur even in prototype strains due to repeated subculturing, which may explain the differences in findings. Despite the lack of correlation in type assignment between PCR-RFLP and conventional typing, this method could still be used for outbreak investigations, where comparison of isolates and differentiation between outbreak strains and nonoutbreak strains is the primary objective.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»